FAST: a randomised phase II study of zolbetuximab (IMAB362
FAST: a randomised phase II study of zolbetuximab (IMAB362,Zero Absorber M-CXXX, Patient Monitoring | GE HealthCare,Population Pharmacokinetics of Sofosbuvir and Its Major,Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2,Brentuximab Vedotin-Based Combination Regimens in Hodgkin